Crossmark

T cell receptor-engineered T cells for leukemia immunotherapy

Crossref DOI link: https://doi.org/10.1186/s12935-018-0720-y

Published Online: 2019-01-03

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, Yikai

Li, Yangqiu https://orcid.org/0000-0002-0974-4036
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81770152, 91642111)

Guangdong Provincial Applied Science and Technology Research & Development Program (2016B020237006)

Guangdong Provincial Basic Research Program (2015B020227003)

Guangzhou Science and Technology Project (201510010211, 20180710004, 201803040017)
License Information

Text and Data Mining valid from 2019-01-03
More Information

Article History

Received: 6 September 2018

Accepted: 24 December 2018

First Online: 3 January 2019